Hudson Bay Capital Management
TNXP icon

Hudson Bay Capital Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Hudson Bay Capital Management’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12
Closed -$123K – 1110
2022
Q3 		$123K Buy
+12
New +$294K ﹤0.01% 933

Other funds holding TNXP

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Hudson Bay Capital Management's TNXP Position: Q4 2022 in Review

Hudson Bay Capital Management sold out of Tonix Pharmaceuticals (TNXP) in Q4 2022, closing a stake of 12 shares — an estimated $123K sold.

Hudson Bay Capital Management first reported a position in TNXP in Q3 2022 and held it in 1 quarter. The position peaked at $123K in Q3 2022. 22 funds tracked by Wall St. Rank hold TNXP as of Q4 2022.

  • Hudson Bay Capital Management reported no remaining Tonix Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Hudson Bay Capital Management sold 12 Tonix Pharmaceuticals shares in Q4 2022, an estimated $123K.
  • Hudson Bay Capital Management first reported a position in Tonix Pharmaceuticals in Q3 2022 and held it in 1 quarter.
  • Hudson Bay Capital Management's Tonix Pharmaceuticals position peaked at $123K in Q3 2022.
  • 22 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q4 2022.

Based on Hudson Bay Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.